THE DEAL, AT A GLANCE
From the announcementVirax Biolabs Group Limited
01Who is involvedBacked by preferred investment options exercise, $5 million from a private placementFrom the announcement
Summarized from the deal record's source announcement; not yet independently reviewed.
Read the announcement ↗02What happenedVirax Biolabs Group Limited raised $3.3M Series A, announced 2026-07-09From the announcement
Summarized from the deal record's source announcement; not yet independently reviewed.
Read the announcement ↗03Why it mattersVirax Biolabs Group Limited's $3.3M Series A is a small-capital signal inside an active Healthcare & Life Sciences funding market, positioning the deal near the lower…From the announcement
Summarized from the deal record's source announcement; not yet independently reviewed.
Read the announcement ↗Click a part to explore its evidence. Unsupported imagery is withheld rather than guessed.Original record source ↗
Virax Biolabs Group Limited · Financing Record
Explore source-linked visual explanations for Virax Biolabs Group Limited. Unsupported claims are withheld while source review continues.
Record 7872 · Recorded date: 2026-07-09
Explore company records →